Nitazoxanide Kills Replicating and Nonreplicating Mycobacterium tuberculosis and Evades Resistance

Journal of Medicinal Chemistry
2009.0

Abstract

We report here that nitazoxanide (NTZ) and its active metabolite kill replicating and nonreplicating M. tuberculosis at low microg/mL levels. NTZ appears to evade resistance, as we were unable to recover resistant colonies, using up to 10(12) colony forming units. Therefore, NTZ is a novel lead compound that kills replicating and nonreplicating M. tuberculosis by a novel mechanism of action, which appears to bypass the development of resistance.

Knowledge Graph

Similar Paper

Nitazoxanide Kills Replicating and Nonreplicating Mycobacterium tuberculosis and Evades Resistance
Journal of Medicinal Chemistry 2009.0
Nitazoxanide Disrupts Membrane Potential and Intrabacterial pH Homeostasis of Mycobacterium tuberculosis
ACS Medicinal Chemistry Letters 2011.0
Synthesis and biological evaluation of substituted 4-arylthiazol-2-amino derivatives as potent growth inhibitors of replicating Mycobacterium tuberculosis H37RV
Bioorganic & Medicinal Chemistry Letters 2011.0
Development of 5-nitrothiazole derivatives: Identification of leads against both replicative and latent Mycobacterium tuberculosis
Bioorganic & Medicinal Chemistry Letters 2012.0
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
Nature 2000.0
1,3-Oxazine-2-one derived dual-targeted molecules against replicating and non-replicating forms of Mycobacterium tuberculosis
European Journal of Medicinal Chemistry 2020.0
The antitubercular activity of various nitro(triazole/imidazole)-based compounds
Bioorganic & Medicinal Chemistry 2017.0
Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and NonreplicatingMycobacterium tuberculosis
Journal of Medicinal Chemistry 2016.0
Synthesis and Antiplasmodial and Antimycobacterial Evaluation of New Nitroimidazole and Nitroimidazooxazine Derivatives
ACS Medicinal Chemistry Letters 2013.0
Metronidazole plus Rifampin Sterilizes Long-Term Dormant Mycobacterium tuberculosis
Antimicrobial Agents and Chemotherapy 2007.0